Wikidata

(Q43426726)

English

Efficacy and safety of taspoglutide in patients with type 2 diabetes inadequately controlled with metformin plus pioglitazone over 24 weeks: T-Emerge 3 trial

scientific article published on 26 April 2012

In more languages

Statements

title
Efficacy and safety of taspoglutide in patients with type 2 diabetes inadequately controlled with metformin plus pioglitazone over 24 weeks: T-Emerge 3 trial (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
22539590
retrieved
23 November 2017
author name string
Robert R Henry
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
22539590
retrieved
23 November 2017
Sunder Mudaliar
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
22539590
retrieved
23 November 2017
Linda Kanitra
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
22539590
retrieved
23 November 2017
Michael Woloschak
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
22539590
retrieved
23 November 2017
Raffaella Balena
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
22539590
retrieved
23 November 2017
T-Emerge 3 Study Group
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
22539590
retrieved
23 November 2017
publication date
26 April 2012
1 reference
stated in
Europe PubMed Central
PubMed ID
22539590
retrieved
23 November 2017
page(s)
2370-2379
1 reference
stated in
Europe PubMed Central
PubMed ID
22539590
retrieved
23 November 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q43426726&oldid=2162450342"